日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Targeting FAM111B attenuates mitophagy and increases the sensitivity to lenvatinib treatment by increasing MFN2 stability in hepatocellular carcinoma

靶向FAM111B可通过增加MFN2在肝细胞癌中的稳定性来减弱线粒体自噬并提高其对乐伐替尼治疗的敏感性。

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-07941-1
Yan, Yu-Chuan; Shao, Li-Juan; Meng, Guang-Xiao; Pan, Guo-Qiang; Li, Rui-Zhe; Xiong, Chen; Liu, Shi-Jia; Ding, Zi-Niu; Zhang, Xiao-Lu; Dong, Xiao-Feng; Qu, Ying; Dong, Zhao-Ru; Li, Tao
肿瘤
肿瘤免疫
MFN2
线粒体
细胞生物学
自噬
发表日期：2025
文献求助 收藏

Thyroid hormones inhibit tumor progression and enhance the antitumor activity of lenvatinib in hepatocellular carcinoma via reprogramming glucose metabolism.

甲状腺激素通过重编程葡萄糖代谢抑制肿瘤进展，增强乐伐替尼在肝细胞癌中的抗肿瘤活性

期刊:Cell Death Discovery
影响因子:7
doi:10.1038/s41420-025-02378-z
Yang Chun-Cheng, Yan Yu-Chuan, Pan Guo-Qiang, Meng Guang-Xiao, Zhang Xiao, Yan Lun-Jie, Ding Zi-Niu, Wang Dong-Xu, Li Rui-Zhe, Li Guang-Zhen, Dong Zhao-Ru, Li Tao
代谢
肿瘤
发表日期：2025
文献求助 收藏

Comparison of tenofovir versus entecavir for preventing hepatocellular carcinoma in chronic hepatitis B patients: an umbrella review and meta-analysis

比较替诺福韦与恩替卡韦在预防慢性乙型肝炎患者肝细胞癌方面的疗效：一项伞状综述和荟萃分析

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-025-06082-4
Liu, Shi-Jia; Zhang, Xiao; Yan, Lun-Jie; Wang, Han-Chao; Ding, Zi-Niu; Liu, Hui; Pan, Guo-Qiang; Han, Cheng-Long; Tian, Bao-Wen; Dong, Zhao-Ru; Wang, Dong-Xu; Yan, Yu-Chuan; Li, Tao
细胞生物学
肿瘤
肝炎
肿瘤免疫
发表日期：2025
文献求助 收藏

Neoadjuvant immunotherapy based on PD-1/L1 inhibitors for gastrointestinal tumors: a review of the rationale and clinical advances

基于PD-1/L1抑制剂的新辅助免疫疗法治疗胃肠道肿瘤：理论基础及临床进展综述

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000001357
Wang, Dong-Xu; Liu, Hui; Tian, Jin-Cheng; Zhang, Dao-Lin; Yan, Lun-Jie; Ding, Zi-Niu; Li, Han; Yan, Yu-Chuan; Dong, Zhao-Ru; Li, Tao
肿瘤
肿瘤免疫
PD-1
免疫/内分泌
发表日期：2024
文献求助 收藏

Correction: MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway

更正：MALAT1/mir-1-3p介导的BRF2表达通过抑制LKB1/AMPK信号通路促进HCC进展

期刊:Cancer Cell International
影响因子:6
doi:10.1186/s12935-024-03399-x
Li, Guang-Zhen; Meng, Guang-Xiao; Pan, Guo-Qiang; Zhang, Xiao; Yan, Lun-Jie; Li, Rui-Zhe; Ding, Zi-Niu; Tan, Si-Yu; Wang, Dong-Xu; Tian, Bao-Wen; Yan, Yu-Chuan; Dong, Zhao-Ru; Hong, Jian-Guo; Li, Tao
信号转导
AMPK
LAT
LAT1
发表日期：2024
文献求助 收藏

Safety, efficacy, and survival outcomes of immune checkpoint inhibitors rechallenge in patients with cancer: a systematic review and meta-analysis

癌症患者再次使用免疫检查点抑制剂的安全性、有效性和生存结果：系统评价和荟萃分析

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyae134
Liu, Shi-Jia; Yan, Lun-Jie; Wang, Han-Chao; Ding, Zi-Niu; Liu, Hui; Zhang, Xiao; Pan, Guo-Qiang; Han, Cheng-Long; Tian, Bao-Wen; Yang, Xiao-Rong; Tan, Si-Yu; Dong, Zhao-Ru; Wang, Dong-Xu; Yan, Yu-Chuan; Li, Tao
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2024
文献求助 收藏

A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patients

基于脂肪和肌肉相关指标，通过CT图像评估的模型，用于预测肝细胞癌患者的微血管侵犯

期刊:Biomarker Research
影响因子:11.5
doi:10.1186/s40364-023-00527-z
Mao, Xin-Cheng; Shi, Shuo; Yan, Lun-Jie; Wang, Han-Chao; Ding, Zi-Niu; Liu, Hui; Pan, Guo-Qiang; Zhang, Xiao; Han, Cheng-Long; Tian, Bao-Wen; Wang, Dong-Xu; Tan, Si-Yu; Dong, Zhao-Ru; Yan, Yu-Chuan; Li, Tao
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway

MALAT1/mir-1-3p介导的BRF2表达通过抑制LKB1/AMPK信号通路促进肝细胞癌进展。

期刊:Cancer Cell International
影响因子:6
doi:10.1186/s12935-023-03034-1
Li, Guang-Zhen; Meng, Guang-Xiao; Pan, Guo-Qiang; Zhang, Xiao; Yan, Lun-Jie; Li, Rui-Zhe; Ding, Zi-Niu; Tan, Si-Yu; Wang, Dong-Xu; Tian, Bao-Wen; Yan, Yu-Chuan; Dong, Zhao-Ru; Hong, Jian-Guo; Li, Tao
肿瘤
肿瘤免疫
信号转导
AMPK
LAT
LAT1
细胞生物学
发表日期：2023
文献求助 收藏

A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response

一种基于铜稳态和铜凋亡的新型预后评分模型，该模型可反映肿瘤微环境的变化并影响治疗反应。

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2023.1101749
Ma, Yun-Long; Yang, Ya-Fei; Wang, Han-Chao; Yang, Chun-Cheng; Yan, Lun-Jie; Ding, Zi-Niu; Tian, Bao-Wen; Liu, Hui; Xue, Jun-Shuai; Han, Cheng-Long; Tan, Si-Yu; Hong, Jian-Guo; Yan, Yu-Chuan; Mao, Xin-Cheng; Wang, Dong-Xu; Li, Tao
凋亡
肿瘤
表观遗传
肿瘤免疫
肿瘤微环境
发表日期：2023
文献求助 收藏

The somatic mutational landscape and role of the ARID1A gene in hepatocellular carcinoma

肝细胞癌中ARID1A基因的体细胞突变图谱及其作用

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2023.e14307
Meng, Guang-Xiao; Yang, Chun-Cheng; Yan, Lun-Jie; Yang, Ya-Fei; Yan, Yu-Chuan; Hong, Jian-Guo; Chen, Zhi-Qiang; Dong, Zhao-Ru; Li, Tao
细胞生物学
肿瘤
肿瘤免疫
ID1
发表日期：2023
文献求助 收藏